BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25988651)

  • 1. [The Medical Products Agency is positive to a dialogue about off-label prescribing].
    Babra A; Arlander E
    Lakartidningen; 2015 May; 112():. PubMed ID: 25988651
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-label prescribing: in search of a reasonable patient-centered approach.
    Rich BA
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):131-3. PubMed ID: 22764850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges to the validity of using medicine labels to categorize clinical behavior: An empirical and normative critique of "off-label" prescribing.
    Ghinea N; Kerridge I; Little M; Lipworth W
    J Eval Clin Pract; 2017 Jun; 23(3):574-581. PubMed ID: 27859988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Defense of Off-label Prescribing.
    Keller DL
    JAMA Intern Med; 2016 Jun; 176(6):861. PubMed ID: 27273485
    [No Abstract]   [Full Text] [Related]  

  • 5. In Defense of Off-label Prescribing-Reply.
    Eguale T; Verma A; Tamblyn R
    JAMA Intern Med; 2016 Jun; 176(6):861-2. PubMed ID: 27273486
    [No Abstract]   [Full Text] [Related]  

  • 6. Off-label prescribing.
    Seale JP
    Med J Aust; 2014 Feb; 200(2):65. PubMed ID: 24484085
    [No Abstract]   [Full Text] [Related]  

  • 7. The challenge of off-label prescribing.
    Phillips J
    Int J Palliat Nurs; 2015 Sep; 21(9):419. PubMed ID: 26412270
    [No Abstract]   [Full Text] [Related]  

  • 8. Off-label use of medical products.
    National Association Of EMS Physicians
    Prehosp Emerg Care; 2011; 15(3):419. PubMed ID: 21612389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What does off-label prescribing really mean?
    O'Malley PG
    Arch Intern Med; 2012 May; 172(10):759-60. PubMed ID: 22507697
    [No Abstract]   [Full Text] [Related]  

  • 10. Off-label prescribing of antidepressants.
    Morales DR; Guthrie B
    BMJ; 2017 Feb; 356():j849. PubMed ID: 28223288
    [No Abstract]   [Full Text] [Related]  

  • 11. Off-Label and Unlicensed Prescribing of Medicines in Paediatric Populations: Occurrence and Safety Aspects.
    Aagaard L
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):215-8. PubMed ID: 26176164
    [No Abstract]   [Full Text] [Related]  

  • 12. Robust systems are needed for off-label prescribing.
    Ross S
    BMJ; 2017 Mar; 356():j1362. PubMed ID: 28314712
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reports. The psychopharmacological off-label prescribing in the treatment of children and adolescents with psychiatric disorders].
    Oehler KU; Romanos M; Uzelli-Schwarz O; Dieffenbach R; Vulturius G; Holtmann M; Wewetzer C
    Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):315-7. PubMed ID: 27434690
    [No Abstract]   [Full Text] [Related]  

  • 14. Off-label prescribing in macular degeneration.
    McCartney M
    BMJ; 2011 Oct; 343():d6778. PubMed ID: 22012651
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-regulatory related factors leading to off-label prescribing in children: A concept map.
    Balan S; Hassali MA; Mak VSL
    Res Social Adm Pharm; 2017 Nov; 13(6):1219-1221. PubMed ID: 28576615
    [No Abstract]   [Full Text] [Related]  

  • 16. Knowledge and perception of off-label drug use amongst prescribing physicians in a tertiary care hospital.
    Kannan S; Bahl A; Khosla PP
    Int J Risk Saf Med; 2015; 27(4):219-23. PubMed ID: 26756895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-Label Prescribing: Justified or Not?
    Ruan X; Kaye AD
    Am J Med Qual; 2016; 31(2):101-2. PubMed ID: 26250929
    [No Abstract]   [Full Text] [Related]  

  • 18. Beyond the Label: Steering the Focus Toward Safe and Effective Prescribing.
    Czaja AS; Fiks AG; Wasserman RC; Valuck RJ;
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557744
    [No Abstract]   [Full Text] [Related]  

  • 19. Off-label use of quetiapine in nursing homes: Does medical specialty of prescribing physicians play a role?
    Müller L; Noseda R; Bertoli R; Bissig M; Ceschi A
    Br J Clin Pharmacol; 2020 Jul; 86(7):1444-1445. PubMed ID: 32100324
    [No Abstract]   [Full Text] [Related]  

  • 20. Experiences with Patient Refusal of Off-Label Prescribing of Psychotropic Medications to Children and Adolescents in Japan.
    Tsujii N; Saito T; Izumoto Y; Usami M; Okada T; Negoro H; Iida J
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):642-5. PubMed ID: 26103533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.